Dopamine signaling pathway

The dopamine signaling pathway is a fundamental neuromodulatory system in the central nervous system that regulates motor control, reward-seeking behavior, motivation, and executive function [1][2]. It functions through the release of the neurotransmitter dopamine, which binds to five distinct G protein-coupled receptors (D1-D5) classified into D1-like (D1, D5) and D2-like (D2, D3, D4) families [1]. The pathway's activity is tightly regulated by the dopamine transporter (DAT), which facilitates reuptake, and enzymes like monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) that mediate degradation [2][3]. Clinical significance arises from its role in various disorders; for instance, the degeneration of dopaminergic neurons in the substantia nigra leads to Parkinson's disease, while dysregulated dopamine levels are central to the pathophysiology of schizophrenia and ADHD [2][4]. Therapeutic strategies targeting this pathway include dopamine precursors like Levodopa, receptor agonists for Parkinson's, and receptor antagonists (antipsychotics) for schizophrenia [4]. Additionally, drugs of abuse often hijack this pathway by increasing synaptic dopamine, leading to addiction [1].

Other names

Dopaminergic systemDopaminergic neurotransmissionDopamine pathway

Modulation of dopamine receptor activity (agonism/antagonism), inhibition of dopamine reuptake, inhibition of enzymatic degradation, and supplementation of metabolic precursors [1][2][4].